Acambis trials

Become an underwriter». All rights reserved. The University of Minnesota is an equal opportunity educator and employer. Skip to main content. University of Minnesota. Driven to Discover. Site Search. Staff Mission Contact Us. Show website. Request information now. Facts Focus: Manufacturer. Current news Acambis extends Sanofi Pasteur licensing agreement on single-dose JE vaccine to India and Indian subcontinent Acambis plc announced that it has extended its ChimeriVax tm -JE vaccine licensing agreement with sanofi pasteur, the vaccines division of the sanofi-aventis Group, to include India and the Indian subcontinent.

Acambis initiates pre-clinical testing with herpes vaccine from Harvard Medical School Acambis plc announced that it has initiated pre-clinical trials with a herpes vaccine, licensed from Harvard University through its Office of Technology Development, with a view to submitting an Investigational New Drug IND application in All contents News: On location.

Request information now Add company to watchlist Recommend company Recommend company. Share on. Important information. The University of Minnesota is an equal opportunity educator and employer. Skip to main content. University of Minnesota. Driven to Discover. Site Search. Staff Mission Contact Us. Acambis launches clinical trial of West Nile vaccine Filed Under :. It is currently undergoing paediatric trials in India and is partnered with Sanofi Pasteur and Bharat Biotech.

Acambis has established a global collaboration with Sanofi Pasteur for further development and commercialisation of the vaccine. Acambis also has the only vaccine in development against Clostridium difficile bacteria, a leading cause of hospital-acquired infections. It also includes various further vaccine candidates in the research and pre-clinical stages.

Acambis is recognised internationally as the leading producer of smallpox vaccines. For safety and prescribing information, please refer to www. More information is available at www.